Abstract:Brain volume decrease is usually connected to neurodegeneration and aging. In this environment, an important percentage of elderly persons suffer from mild cognitive impairment (MCI), a kind of dementia that can lead to Alzheimer's disease (AD). Since the symptoms of cognitive impairment are scarcely discernible, developing a safe and effective method for early MCI detection has emerged as an important challenge. According to this regard, numerous cognitive training tests can be targeted to help aging people retain a good quality of life, especially in the case of fragility disorders. A Consortium to Establish a Registry for Alzheimer's Disease (CERAD) task was initially created to detect the early stages of AD. This task specifically targets various tests related to specific cognitive domains. However, it has since developed into a popular diagnostic tool for many kinds of dementia, such as MCI. Several low-cost equipment, such as electroencephalography (EEG) and heart rate variability (HRV), may be useful for predicting MCI. On the other side, various machine learning (ML) models can be employed to extract/analyze relevant features from biomedical and physiological signals, especially in the context of anomaly detection and classification. To this regard, we developed a new method based on ML models to categorize MCI and healthy control (HC) patients during the CERAD task using EEG and HRV multimodal data. Our dataset includes 15 subjects who were randomly assigned to training and testing groups of 7 HC and 8 MCI, respectively. Our raw EEG and HRV data are analyzed to extract time, frequency, and non-linear features. A scaling step is employed to reduce the significant disparity between features. For the classification task, five ML models are evaluated, including support vector machine (SVM), k-nearest neighbors (KNN), decision tree (DT), random forest (RF), and gradient boosting (GB). To enhance accuracy, a hybrid ML model with a voting system is developed, combining the top ML models with the highest accuracy rates. A comparison step is performed between the use of ML and hybrid ML models. The experimental findings demonstrated the efficacy of our proposed technique, which included a hybrid ML model. An average accuracy of 93.86%, a sensitivity of 93.87%, and a specificity of 93.53% are achieved. The obtained results allow one to conclude that the first CERAD test plays a prominent role as a novel biomarker with an ultra-short duration for early MCI identification through the combination of EEG and HRV signals.

Prediction of Mild Cognitive Impairment Status: Pilot Study of Machine Learning Models Based on Longitudinal Data From Fitness Trackers

Digitized Biomarkers Utilizing Human‐Computer Interaction Sensing Technology for Early Auxiliary Diagnosis of Alzheimer’s Disease

Feasibility of Using a Novel, Multimodal Motor Function Assessment Platform With Machine Learning to Identify Individuals With Mild Cognitive Impairment

Investigating Predictors of Progression from Mild Cognitive Impairment to Alzheimer’s Disease Based on Different Time Intervals

Identification of Mild Cognitive Impairment Using Extreme Learning Machines Model.

Predicting mild cognitive impairment among Chinese older adults: a longitudinal study based on long short-term memory networks and machine learning

Assessing cognitive function among older adults using machine learning and wearable device data: a feasibility study

Synergy through integration of digital cognitive tests and wearable devices for mild cognitive impairment screening

An aid diagnostic platform to detect the transition of mild cognitive impairment (MCI) to Alzheimer's disease (AD) based on 48,116 AD and MCI patients

Predictive power of gait and gait-related cognitive measures in amnestic mild cognitive impairment: a machine learning analysis

Predicting Mild Cognitive Impairment in Older Adults: A Machine Learning Analysis of the Alzheimer's Disease Neuroimaging Initiative.

Mild Cognitive Impairment detection based on EEG and HRV data

Predicting the severity of mood and neuropsychiatric symptoms from digital biomarkers using wearable physiological data and deep learning

Predicting cognitive scores from wearable-based digital physiological features using machine learning: data from a clinical trial in mild cognitive impairment

Establishment of a Mild Cognitive Impairment Risk Model in Middle-Aged and Older Adults: a Longitudinal Study

Predicting the Development of Mild Cognitive Impairment: A New Use of Pattern Recognition

MACHINE-LEARNING-BASED INTERPRETABLE PREDICTION FOR MILD COGNITIVE IMPAIRMENT: FROM ADNI DATABASE

Machine learning-based prediction of mild cognitive impairment among individuals with normal cognitive function

Machine Learning Approach for Improved Longitudinal Prediction of Progression from Mild Cognitive Impairment to Alzheimer’s Disease

Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers

Behavioral marker-based predictive modeling of functional status for older adults with subjective cognitive decline and mild cognitive impairment: Study protocol